Corpus overview


MeSH Disease

HGNC Genes

SARS-CoV-2 proteins

There are no SARS-CoV-2 protein terms in the subcorpus


SARS-CoV-2 Proteins
    displaying 1 - 1 records in total 1
    records per page

    Clinical course and characteristics of Corona Virus Disease 2019 in Xiaoshan, Hangzhou: A Retrospective study

    Authors: Yongtao Zheng; Hexiang Jia; Fuliang Wang; Xiangjue Sun; Dongbo Yang; Miaojian Xu; Diwei Xu; Chao Lu; Bo Ge; Shenglan Chen; Biao Li; Ting Chen; Zhibo Li; Yuanmei Feng; Fenhua Lai

    doi:10.21203/ Date: 2020-04-08 Source: ResearchSquare

    Background: The World Health Organization declared the outbreak a public health emergency of international concern ( Corona Virus Disease MESHD 2019) on January 30th, this study aimed to investigate the epidemiological and clinical characteristics of Corona Virus Disease MESHD 2019 in Xiaoshan, Hangzhou, and evaluate scientific basis for disease control and prevention. Methods: A total of 30 patients had been admitted to hospital from Jan 22 to Feb 22, 2020, all of them were laboratory confirmed SARS-Cov-2. Demographic, epidemiological, clinical, laboratory data were collected from Hospital information system and Epidemiological investigation reports. All data was performed by descriptive analysis, Chi-square test or non-parametric Mann-Whitney U test, as appropriate. Two sided p value less than 0.05 was considered statistically significant.Results: 30 patients were enrolled, the median age was 44.5 years (IQR 33.8-52.3) and 17 (56.7%) patients were female, 14 (46.7%) patients were native and had no exposure to Hubei Province. At the time of study submission, only one patient had not been discharged and no patients died during the study. The median hospital stay was 16.0 days (IQR 12.5-20.5) and the median course of disease was 20.5 days (IQR 17.0-23.3). The most common symptoms were fever MESHD (66.7%), dry cough MESHD (26.7%), and pharyngalgia (23.3%) on first admission. Most patients were generally illness or more mild, but 10 (33.3%) patients received oxygen therapy and 14 (46.7%) patients received hormone therapy during their hospitalization. Almost half of patients showed mild lymphocytopenia MESHD and 40% patients had elevated concentrations of CRP HGNC in the early stages of COVID-19 MESHD.´╗┐Conclusions: Among the 30 patients were confirmed with SARA HGNC-Cov-2 infection in Xiaoshan, Hangzhou, most of them had clinical presentation of respiratory tract infection MESHD, but the median course of disease was more than 2 weeks. Further systematic prospective studies about COVID-19 MESHD should be urgently needed.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
HGNC Genes
SARS-CoV-2 Proteins

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.